Dr. Albala on the recent CMS change for Rezum water vapor therapy

“I think this really now suggests that Rezum is a financially viable procedure across these different treatment settings…the reimbursement now is really quite favorable,” says David M. Albala, MD.

In this video, David M. Albala, MD, discusses the recent change made by the Centers for Medicare & Medicaid Services regarding Rezum water vapor therapy. This new change allows for more financial coverage for patients with benign prostatic hyperplasia (BPH) who seek this treatment. Albala is a urologist at Associate Medical Professionals and chief of urology at Crouse Hospital in Syracuse, New York.

Related Videos
Doctor receiving patient in office | Image Credit © Africa Studio - stock.adobe.com
Alisa J. Stephens-Shields, PhD, answers a question during a Zoom video interview
Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
Dr. David Sheyn in an interview with Urology Times
Avinash Maganty, MD, answers a question during a Zoom video interview
Rachel Pope, MD, MPH, answers a question during a Zoom interview
Dr. David Canes in an interview with Urology Times
Rachel Pope, MD, MPH, answers a question during a Zoom video interview
© 2023 MJH Life Sciences

All rights reserved.